可能影響子宮內膜基因表現&相關蛋白產量,進一步影響胚胎著床
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039220/
In summary, infertility in endometriosis is not exclusively due to poor oocyte quality or embryo development but also the result of defective implantation. Decreased expression of implantation markers during the window of implantation, silencing of the HOXA10 gene, due to hypermethylation and progesterone resistance may lead to impaired implantation in endometriosis.
Table I
Gynecological disease | Proposed mechanism of implantation failure |
---|---|
Endometriosis | Reduced αvβ3 integrin and LIF expressions in the window of implantation |
Lack of IL-11 and IL-11Rα expressions in secretory phase | |
Absence of HOXA10 and HOXA11 peak in secretory phase | |
Elevated EMX2 expression | |
Progesterone resistance | |
Alteration in PR-A to PR-B ratio | |
Decreased HOXA10 expression due to hypermethylation of its promoter region | |
Hydrosalpinx | Mechanical interference to apposition by bathing of endometrial lining with hydrosalpinx fluid intermittently |
Reduced avβ3 integrin and LIF expressions | |
Decreased HOXA10 expression | |
Leiomyoma | Distorting endometrial lining |
Obstructing the tubal ostia or cervical canal | |
Decreased HOXA10 and BTEB1 expressions | |
Endometrial polyp | Mechanical interference with sperm transport and embryo implantation |
Low IGFBP-1 and osteopontin levels in secretory phase | |
Low progesterone receptor levels in secretory phase | |
PCOS | Decreased αvβ3 integrin, HOXA-10 and IGFBP-1 during secretory phase |
Overexpression of androgen receptors | |
Failure to downregulate estrogen receptor-α in the window of implantation | |
Overexpression of the steroid receptor coactivators AIB1 and TIF2 |
沒有留言:
張貼留言